Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Alan G. Zimmermann
ResearcherPublications, citations & collaboration network
Alan G. Zimmermann is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 60 works, 2,654 citations, an h-index of 28 and an i10-index of 32.
60
Works
2,654
Citations
28
h-index
32
i10-index
IDs:OpenAlex
How has Alan G. Zimmermann's publication output changed over time?
ScholarIQpublication output · 1989–2019
Output grew0% over the shown period — from 1 works in 1989 to 1 in 2019.
1
1
1
1
1
2
1
2
1
198920032007200920112013201520182019
What are the most-cited papers on Alan G. Zimmermann?
ScholarIQmost cited works
Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial
Katherine R Tuttle, Mark Lakshmanan, Brian Rayner, Robert S. Busch, Alan G. Zimmermann, D. Bradley Woodward, Fady T. Botros
The Lancet Diabetes & Endocrinology. 2018645 Citations
Efficacy and Safety of Once-Weekly Dulaglutide Versus Insulin Glargine in Patients With Type 2 Diabetes on Metformin and Glimepiride (AWARD-2)
Francesco Giorgino, Marian Benroubi, Jui‐Hung Sun, Alan G. Zimmermann, V. Pechtner
Diabetes Care. 2015263 CitationsOPEN ACCESS
The epidemiology of neonatal tumours
Simon W. Moore, Daniel Satg�, Annie J. Sasco, Alan G. Zimmermann, J. Plaschkes
Pediatric Surgery International. 2003156 Citations
Prevalence of Metabolic Syndrome in Adult Hypopituitary Growth Hormone (GH)-Deficient Patients Before and After GH Replacement
Andrea Attanasio, Daojun Mo, Eva Marie Erfurth, Meng H. Tan, Ken Ho, David L. Kleinberg, Alan G. Zimmermann, Philippe Chanson
The Journal of Clinical Endocrinology & Metabolism. 2009115 CitationsOPEN ACCESS
GH Treatment to Final Height Produces Similar Height Gains in Patients With SHOX Deficiency and Turner Syndrome: Results of a Multicenter Trial
Werner Blum, Judith L. Ross, Alan G. Zimmermann, Charmian A. Quigley, Christopher J. Child, G. Kalifa, Cheri Deal, Stenvert L. S. Drop, Gudrun Rappold, Gordon B. Cutler
The Journal of Clinical Endocrinology & Metabolism. 2013103 CitationsOPEN ACCESS
Related on ScholarIQ
Eli Lilly (United States)
Institution
Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial
Paper
Efficacy and Safety of Once-Weekly Dulaglutide Versus Insulin Glargine in Patients With Type 2 Diabetes on Metformin and Glimepiride (AWARD-2)
Paper
The epidemiology of neonatal tumours
Paper
Prevalence of Metabolic Syndrome in Adult Hypopituitary Growth Hormone (GH)-Deficient Patients Before and After GH Replacement
Paper
GH Treatment to Final Height Produces Similar Height Gains in Patients With SHOX Deficiency and Turner Syndrome: Results of a Multicenter Trial
Paper